BioCentury
ARTICLE | Clinical News

Canvaxin regulatory update

February 3, 2003 8:00 AM UTC

The FDA granted Fast Track designation to CancerVax's Canvaxin vaccine for the post-surgical treatment of metastatic melanoma. Canvaxin is in two Phase III trials in patients with Stage III or IV mela...